| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.45 | 0.002 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |